Company tracker
Stages reflect publicly traceable evidence, not proposed launch dates. Company statements are labelled and do not constitute independent validation.
United Kingdom / Guatemala
Autologous dermal papilla cell expansion and follicle rejuvenation
Company reports clinical evaluation with a partner clinic; follicle banking is commercially available.
Primary source ↗United States
iPSC-derived engineered follicular units intended to create new follicles
Company has reported human hair formation in humanised mouse models and an Aderans licensing partnership.
Primary source ↗Japan
Regeneration of functional follicular units using epithelial, dermal papilla and supporting cells
Reported a defined three-cell in-vitro regeneration system in 2026.
Primary source ↗South Korea
Autologous dermal papilla cell product EPI-001
A dose-escalation and placebo-controlled expansion study is registered for androgenetic alopecia.
Primary source ↗Inclusion is not endorsement. Developers can request factual corrections at editor@haircloning.info.